MTOR and cancer: Although no evaluation was performed on the PI3K downstream factors, the observed apoptosis, cell cycle arrest, and subsequent suppressed progression of different cancers [77, 81] imply that mTOR downstream factors that cause apoptosis and cell death must have been activated by treatment with CGs.